RACHELLE WEBSTER: Open Payments
NPI 1609892678 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,461 in 179 payments from 29 companies in 2025. Trend: 2023 $2,082 · 2024 $4,123 · 2025 $11,461
Speaker / faculty: $7,454Food & beverage: $3,966Travel & lodging: $41
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 58 | $8,459 |
| PFIZER INC. | 29 | $549 |
| Lundbeck LLC | 10 | $420 |
| Axsome Therapeutics, Inc. | 5 | $306 |
| Neurocrine BioSciences, Inc. | 14 | $270 |
| SK Life Science, Inc. | 5 | $227 |
| Teva Pharmaceuticals USA, Inc. | 11 | $196 |
| Neurelis, Inc. | 5 | $132 |
| Novartis Pharmaceuticals Corporation | 5 | $93 |
| Ipsen Biopharmaceuticals, Inc | 3 | $84 |
Products named: UBRELVY, QULIPTA, VYEPTI, NURTEC ODT, Symbravo, INGREZZA, VALTOCO, AUSTEDO XR.
Industry payments across CO — which companies pay providers there.
